We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NXEN market cap is 384.59k. The company's latest EPS is USD -0.0035 and P/E is -2.86.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.67M | -1.84M | -564k | -283k | -156k |
| Net Income | -2.67M | -1.86M | -626k | -362k | -239k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23k | 26k | 125k | 43k | 4k |
| Total Liabilities | 29k | 40k | 242k | 295k | 365k |
| Total Equity | -6k | -14k | -117k | -252k | -361k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -147k | -91k | -75k | -82k | -64k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 12k | 98k | 174k | N/A | 33k |
| Market Cap | 384.59k |
| Price to Earnings Ratio | -2.86 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 100 |
| Price to Book Ratio | -1.87 |
| Dividend Yield | - |
| Shares Outstanding | 67.47M |
| Average Volume (1 week) | 4.5k |
| Average Volume (1 Month) | 31.43k |
| 52 Week Change | -84.08% |
| 52 Week High | 0.0495 |
| 52 Week Low | 0.0041 |
| Spread (Intraday) | 0.02 (94.92%) |
| Company Name | Nexien BioPharma Inc (PK) |
| Address |
16192 coastal highway lewes, delaware 19958 |
| Website | https://nexienbiopharma.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
